lobbying_activities: 2683909

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2683909	d207093d-26aa-471c-a1bc-1d48d99ec587	Q3	MEHLMAN CONSULTING, INC.	284950	AMNEAL	2021	third_quarter	PHA	Monitoring legislative and regulatory efforts related to domestic supply chains of generic drugs. Pandemic Preparedness. The Build Back Better Act, a bill to provide for reconciliation pursuant to title II of the Concurrent Resolution on the Budget for Fiscal Year 2022, S. Con. Res. 14.	Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office	60000		0	0	2021-10-18T09:37:51.060000-04:00